Biotech · Private company · San Francisco, CA, US
Vivid Bioinnovations, Pbc
Track this companyFree. Adds Vivid Bioinnovations, Pbc to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards10
- AstroTarget™ Astro-Enrichment Kit: A Microfluidic-Free Platform for High-Throughput Rare-Astrocyte Isolation and Multi-Omic Profiling from Frozen Alzheimer’s BrainFiscal year 2026 · $506.5KNIH RePORTER 1R44AG102286-01 · fetched Nov 12, 2026
- HIVE-seq: A Novel Omics Technology to Profile Thousands of Single HIV-Positive CellsFiscal year 2026 · $307.1KNIH RePORTER 1R44AI195215-01 · fetched Nov 12, 2026
- Spatially Resolved Single-Cell DNA Sequencing: A General Spatial Genomics Platform with Application to HIV Reservoir MappingFiscal year 2026 · $300KNIH RePORTER 1R44AI197850-01 · fetched Nov 12, 2026
- Ultrahigh-Throughput Cell Interaction Screening to Advance CAR-T Therapeutic DevelopmentFiscal year 2026 · $306.9KNIH RePORTER 1R44CA310740-01 · fetched Nov 12, 2026
- Integrated High-Throughput Microfluidic-Mass Spectrometry for Enhanced Biomedical Data Generation and AI Model TrainingFiscal year 2026 · $300KNIH RePORTER 1R44GM163514-01 · fetched Nov 12, 2026
- FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human TissuesFiscal year 2026 · $1MNIH RePORTER 4R44AG091101-02 · fetched Nov 12, 2026
- A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass SpectrometryFiscal year 2026 · $1MNIH RePORTER 4R44GM161309-02 · fetched Nov 12, 2026
- FIND-seq: A Novel Cell Sorting Technology to Enable Investigation of Rare Cells in Primary Human TissuesFiscal year 2025 · $306.9KNIH RePORTER 1R44AG091101-01A1 · fetched Nov 12, 2026
- A Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution With micro-Mass SpectrometryFiscal year 2025 · $306.9KNIH RePORTER 1R44GM161309-01 · fetched Nov 12, 2026
- Multiplexed Nucleic Acid Self-Test for Reproducible and Sensitive HIV DetectionFiscal year 2025 · $595.3KNIH RePORTER 75N93025C00029-0-9999-1 · fetched Nov 12, 2026